ExcelFin Acquisition Corp. (NASDAQ:XFIN – Get Rating) saw a large decrease in short interest in October. As of October 31st, there was short interest totalling 16,000 shares, a decrease of 26.3% from the October 15th total of 21,700 shares. Based on an average daily volume of 48,500 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.1% of the shares of the stock are sold short.
Institutional Trading of ExcelFin Acquisition
Large investors have recently modified their holdings of the stock. Clear Street LLC acquired a new stake in ExcelFin Acquisition in the first quarter valued at about $54,000. Robinson Capital Management LLC acquired a new stake in ExcelFin Acquisition in the third quarter valued at about $61,000. Virtu Financial LLC acquired a new stake in ExcelFin Acquisition in the third quarter valued at about $110,000. Landscape Capital Management L.L.C. acquired a new stake in ExcelFin Acquisition in the third quarter valued at about $208,000. Finally, Wolverine Asset Management LLC boosted its stake in ExcelFin Acquisition by 38.3% in the third quarter. Wolverine Asset Management LLC now owns 49,697 shares of the company's stock valued at $497,000 after buying an additional 13,774 shares in the last quarter. 63.94% of the stock is owned by institutional investors and hedge funds.
Get ExcelFin Acquisition alerts:ExcelFin Acquisition Price Performance
XFIN opened at $10.06 on Friday. ExcelFin Acquisition has a 52-week low of $9.67 and a 52-week high of $10.50. The business's fifty day moving average is $10.01 and its 200-day moving average is $9.98.
ExcelFin Acquisition Company Profile
(Get Rating)ExcelFin Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in San Francisco, California.
Featured Stories
- Get a free copy of the StockNews.com research report on ExcelFin Acquisition (XFIN)
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
Receive News & Ratings for ExcelFin Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ExcelFin Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.